Founded in Queensbury in 1988, AngioDynamics develops and manufactures medical devices for minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. Its global portfolio includes technologies such as the NanoKnife system for electrical tumor ablation and the Auryon system for peripheral artery disease, supported by manufacturing facilities in New York and worldwide operations. The company is a NASDAQ-listed public company serving physicians through direct sales and distribution partners.
Nissha Medical TechnologiesWith roots stretching back more than a century, Nissha Medical Technologies designs and manufactures single-use medical technologies, including complex minimally invasive devices and clinical wearables. The Buffalo-headquartered medical devices subsidiary of Japan’s publicly held Nissha Co. operates 10 facilities across five countries, combining product design, regulatory expertise and scalable production. It also brings more than 30 years of experience to complex cable assemblies used in critical-care procedures and holds ISO 13485 certification.BUFFALO, NY
Argon Medical DevicesFounded in 1972 as a guidewire manufacturer, Argon Medical Devices now makes specialty interventional medical devices and provides contract manufacturing for other medical-device companies. Its more than 1,000 employees serve hospitals and clinics in over 114 countries, with products spanning procedures such as biopsy, thrombectomy and drainage. Argon maintains ISO 13485:2016 and MDSAP quality systems and operates manufacturing facilities including its primary site in Athens, Texas.HENRIETTA, NY
Kaneka Medical America LLCKaneka Medical America develops and manufactures neurovascular medical devices, including the i-ED Coil System for endovascular embolization and the WaveSelect guidewire for navigating complex anatomy. A U.S. subsidiary of Kaneka Americas Holding, it works with Kaneka Corporation in Japan, which commercialized Japan’s first neurovascular embolization coil in 2002. The company operates from New York City with research and development in California and entered the U.S. market in 2021.NEW YORK, NY